medigraphic.com
ISSN 0016-3813 (Print)

2013, Number 2

<< Back Next >>

Gac Med Mex 2013; 149 (2)

Association between adiposity, inflammation and cardiovascular risk factors in school-aged Mexican children

Balas-Nakash M, Perichart-Perera O, Benítez-Arciniega A, Tolentino-Dolores M, Mier-Cabrera J, Vadillo-Ortega F

Language: Spanish
References: 45
Page: 196-203
PDF size: 114.91 Kb.


ABSTRACT

Objective: To evaluate the differences in inflammation markers and cardiovascular risk factors in a group of school-aged children with and without excessive adiposity. To examine the relationship between adiposity, inflammation, and cardiovascular risk factors. Methods: Cross-sectional study of 285 school children (8-12 years old). Adiposity (body mass index, BMI, total body fat, TBF, and waist circumference), inflammatory markers (C-reactive protein [CRP], interleukin 1β [IL-1β, interleukin 6 [IL-6], and tumor necrosis factor-α[TNF-α]) and cardiovascular risk factors were analyzed. Mean differences were calculated and multiple regression models were made. Results: Obese children had higher concentrations of CRP and IL-1β; children with abdominal obesity also had higher CRP levels. A higher BMI was associated with higher blood pressure, and higher total cholesterol, triglycerides-TAG, and insulin concentrations, and with lower HDL-cholesterol. The CRP and IL-1β concentrations correlated significantly with the three adiposity indices. The IL-6 concentrations were associated with TAG, and IL-1β with HDL-cholesterol concentration, after adjustment by BMI. Discussion: In a group of school-aged Mexican children, obesity increases cardiovascular risk and inflammation. Both IL-6 and IL-1β appear to be factors involved in lipid alterations in these children. More research is needed in order to explore the role of subclinical inflammation in the development of cardiovascular alterations that have already been described in Mexican children with obesity.


REFERENCES

  1. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;103:1175-82.

  2. Del Río-Navarro BE, Velázquez-Monroy O, Sánchez-Castillo CP, et al. The high prevalence of overweight and obesity in Mexican children. Obes Res. 2004;12(2):215-23.

  3. Perichart-Perera O, Balas-Nakash M, Schiffman-Selechnik E, Barbato- Dosal A, Vadillo-Ortega F. Obesity increases metabolic syndrome risk factors in school-aged children from an urban school in Mexico city. J Am Diet Assoc. 2007;107(1):81-91.

  4. American Heart Association Scientific Statement. Diet and lifestyle recommendations. Revision 2006. A scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82-96.

  5. Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm. 2010;2010:535918.

  6. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-9.

  7. Kones R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther. 2011;5:325-80.

  8. Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci. 2009;54(9):1847-56.

  9. Akinci G, Akinci B, Coskun S, Bayindir P, Hekimsoy Z, Ozmen B. Evaluation of markers of inflammation, insulin resistance and endothelial dysfunction in children at risk for overweight. Hormones. 2008;7(2):156-62.

  10. Caballero AE, Bousquet-Santos K, Robles-Osorio L, et al. Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diabetes Care. 2008;31(3):576-82.

  11. Roh EJ, Lim JW, Ko KO, Cheon EJ. A useful predictor of early atherosclerosis in obese children: serum high-sensitivity C-reactive protein. J Korean Med Sci. 2007;22(2):192-7.

  12. De Ferranti SD, Gauvreau K, Ludwig DS, Newburger JW, Rifai N. Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. Clin Chem. 2006;52(7):1325-30.

  13. Gillum RF. Association of serum C-reactive protein and indices of body fat distribution and overweight in Mexican American children. J Natl Med Assoc. 2003;95(7):545-52.

  14. Dos Santos MG, Pegoraro M, Sandrini F, Macuco EC. Risk factors for the development of atherosclerosis in childhood and adolescence. Arq Bras Cardiol. 2008;90(4):276-83.

  15. Shea S, Aymong E, Zybert P, et al. Obesity, fasting plasma insulin, and C-Reactive protein levels in healthy children. Obes Res. 2003; 11(1):95-103.

  16. Soriano-Guillen L, Hernández-García B, Pita J, Domínguez-Garrido N, Del Río-Camacho G, Rovira A. High-sensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents. Eur J Endocrinol. 2008;159(1):R1-4.

  17. Wu DM, Chu NF, Shen MH, Wang SC. Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan. Clin Biochem. 2006;39(8):810-5.

  18. Lambert M, Delvin EE, Paradis G, O’Loughlin J, Hanley JA, Levy E. C-reactive protein and features of the metabolic syndrome in a population- based sample of children and adolescents. Clin Chem. 2004; 50(10):1762-8.

  19. Galcheva S, Lotova V, Yotov Y, Bernasconi S, Street M. Circulating proinflammatory peptides related to abdominal adiposity and cardiometabolic risk factors in healthy prepubertal children. Eur J Endocrinol. 2011;164(4):553-8.

  20. Moran A, Steffen L, Jacobs D, et al. Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth. Diabetes Care. 2005;28:1763-8.

  21. Goldaracena-Azuara M, de la Cruz-Mendoza E, Flores-Sánchez J, Vargas- Morales JM, Aradillas-García C. Resistencia a la insulina E Interleucina- 6, Factor de necrosis tumoral ALFA en población infantil de San Luis Potosí. Resúmenes de trabajos libres. Bioquimia. 2005;30(Suppl A):135.

  22. Balas-Nakash M, Benítez-Arciniega A, Perichart-Perera O, Valdés-Ramos R, Vadillo-Ortega F. The effect of exercise on cardiovascular risk markers in Mexican school-aged children: comparison between two structured group routines. Salud Pública de Mex. 2010;52(5):398-405.

  23. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499-511.

  24. Lohman T, Roche A, Martorell R. Anthropometric standardization reference manual. Champaign, IL.: Human Kinetics Books; 1991.

  25. Kuczmaski R, Oqden C, Grummer-Strawn L, et al. CDC growth charts: United States. Advance data. 2000;314(1):1-27.

  26. Williams D, Going S, Lohman T, et al. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health. 1992;82(3):358-63.

  27. Expert Panel on the Identification and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. National Institutes of Health. EE.UU., 1998.

  28. Klunder-Klunder M, Flores-Huerta S. Waist circumference values according to height percentiles: A proposal to evaluate abdominal obesity in Mexican children and adolescents between 6 and 16 years of age. Arch Med Res. 2011;42(6):515-22.

  29. Brasil AR, Norton RC, Rossetti MB, Leao E, Mendes RP. C-reactive protein as an indicator of low intensity inflammation in children and adolescents with and without obesity. J Pediatr. 2007;83(5):477-80.

  30. Kim J, Bhattacharjee B, Kheirandish-Gozal L, et al. Insulin sensitivity, serum lipids, and systemic inflammatory markers in school-aged obese and nonobese children. Int J Pediatr. 2010;2010:846098.

  31. Álvarez JA, Higgins PB, Oster RA, Férnandez JR, Darnell BE, Gower BA. Fasting and postprandial markers of inflammation in lean and overweight children. Am J Clin Nutr. 2009;89:1138-44.

  32. Revenga-Frauca J, González-Gil EM, Bueno-Lozano G, et al. Abdominal fat and metabolic risk in obese children and adolescents. J Physiol Biochem. 2009;65(4):415-20.

  33. Ford ES, Ajani UA, Mokdad AH; National Health and Nutrition Examination. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care. 2005;28(4):878-81.

  34. Warnberg J, Nova E, Moreno L, et al. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr. 2006;84:505-12.

  35. Kelishadi R, Sharifi M, Khosravi A, Adeli K. Relationship between Creactive protein and atherosclerotic risk factors and oxidative stress markers among young persons 10-18 years old. Clin Chem. 2007;53(3):456-64.

  36. Hardardóttir I, Moser AH, Memon R, Grünfeld C, Feingold KR. Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. Lymphokine Cytokine Res. 1994;13(3):161-6.

  37. Argiles JM, López-Soriano FJ, Evand RD, Williamson DH. Interleukin-1 and lipid metabolism in rat. Biochem J. 1989;259:673-8.

  38. Cartier A, Lemieux I, Almeras N, Tremblay A, Bergeron J, Despres JP. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab. 2008;93(5):1931-8.

  39. Beasley L, Koster A, Newman A, et al. Inflammation and race and gender differences in computerized tomography-measured adipose depots. Obesity. 2009;17:1062-9.

  40. Pou K, Massaro J, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress. The Framingham Heart Study. Circulation. 2007;116:1234-41.

  41. Yeste D, Vendrell J, Tomasini R, et al. Interlukin-6 in obese children and adolescents with and without glucose intolerance. Diabetes Care. 2007;30(7):1892-4.

  42. Fernández-Real J, Broch M, Vendrell J, Richart C, Ricart W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab. 2000;85:1334-9.

  43. Mendall M, Parel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart. 1997;78(3):273-7.

  44. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr. 2001;138(4):486-92.

  45. Dixon D, Goldberg R, Schneiderman N, Delamater A. Gender differences in TNF-alpha levels among obese vs nonobese Latino children. Eur J Clin Nutr. 2004;58(4):696-9.




2020     |     www.medigraphic.com